Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Pump and dump

<< Previous

Bullboard Posts

Next >>

Comment by PWIB123on Jan 13, 2022 2:35pm

163 Views

Post# 34313924

RE:Pump and dump

Hard to imagine anyone successfully pumping and dumping this thing on such low volume. That said, someone's buying in the morning and the sellers come to the table all afternoon. 18 days and counting (1/31) for THTX to convince me not to join the sellers and unload and invest elsewhere.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec